Indoramin hydrochloride

This classification denotes a beta-adrenergic blocking agent with the molecular formula C22H25N3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DQ0Z3K8W92, chemically known as benzamide, n-(1-(2-(1h-indol-3-yl)ethyl)-4-piperidinyl)-, monohydrochloride but more generally known as indoramin hydrochloride, which bears US NIH Compound Identifier 38102. European Medicines Agency schedules Indoramin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02679MIG. Most nations, for tariff and trade purposes, schedule indoramin hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, INDORAMIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C1CCC(CC1)C(=O)NC2CCN(CC2)CCC3C[NH]C4C3CCCC4.CL.